Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Current Leases: 2020-2024

Historic Current Leases for Mereo BioPharma Group (MREO) over the last 5 years, with Dec 2024 value amounting to $707,000.

  • Mereo BioPharma Group's Current Leases fell 46.06% to $397,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $397,000, marking a year-over-year decrease of 46.06%. This contributed to the annual value of $707,000 for FY2024, which is 8.44% up from last year.
  • According to the latest figures from FY2024, Mereo BioPharma Group's Current Leases is $707,000, which was up 8.44% from $652,000 recorded in FY2023.
  • Mereo BioPharma Group's Current Leases' 5-year high stood at $838,463 during FY2021, with a 5-year trough of $564,000 in FY2022.
  • In the last 3 years, Mereo BioPharma Group's Current Leases had a median value of $652,000 in 2023 and averaged $641,000.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 32.73% in 2022, then climbed by 15.60% in 2023.
  • Over the past 5 years, Mereo BioPharma Group's Current Leases (Yearly) stood at $816,717 in 2020, then climbed by 2.66% to $838,463 in 2021, then crashed by 32.73% to $564,000 in 2022, then rose by 15.60% to $652,000 in 2023, then climbed by 8.44% to $707,000 in 2024.